Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oesophageal squamous cell cancer: chemoradiotherapy versus chemotherapy and surgery - feasibility study
2009-013877-16Phase 3Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Oct 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin, capecitabine and fluorouracil in Esophageal Squamous Cell Carcinoma (ESCC) (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Feasibility of randomization. Started Oct 2009; status: completed.
02
Drugs
cisplatincapecitabinefluorouracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on 2009-013877-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013877-16.